Low anaerobic threshold and increased skeletal muscle lactate production in subjects with Huntington's disease-Reference-Cited by-同舟云学术

Low anaerobic threshold and increased skeletal muscle lactate production in subjects with Huntington's disease

Published:2010-10-07 Issue:1 Volume:26 Page:130-137
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Ciammola Andrea,Sassone Jenny,Sciacco Monica,Mencacci Niccolò E.,Ripolone Michela,Bizzi Caterina,Colciago Clarissa,Moggio Maurizio,Parati Gianfranco,Silani Vincenzo,Malfatto Gabriella

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference36 articles.

1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes;HDCRG;Cell,1993

2. Widespread expression of Huntington's disease gene (IT15) protein product;Sharp;Neuron,1995

3. Myopathy as a first symptom of Huntington's disease in a Marathon runner;Kosinski;Mov Disord,2007

4. Use of hand-held dynamometry in the evaluation of lower limb muscle strength in people with Huntington's disease;Busse;J Neurol,2008

5. Rate and correlates of weight change in Huntington's disease;Hamilton;J Neurol Neurosurg Psychiatr,2004

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain–Periphery Interactions in Huntington’s Disease: Mediators and Lifestyle Interventions;International Journal of Molecular Sciences;2024-04-25

2. Dietary fasting and time-restricted eating in Huntington’s disease: therapeutic potential and underlying mechanisms;Translational Neurodegeneration;2024-04-02

3. Transmission-selective muscle pathology induced by the active propagation of mutant huntingtin across the human neuromuscular synapse;Frontiers in Molecular Neuroscience;2024-01-03

4. Selective vulnerability in Huntington's disease: From excitotoxicity, mitochondrial dysfunction, and transcription dysregulation to therapeutic opportunity;Huntington's Disease;2024

5. Fragment-based virtual screening identifies a first-in-class preclinical drug candidate for Huntington’s disease;Scientific Reports;2022-11-16